Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Pharmacoeconomics|July 21, 2007
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary diseaseMaureen P M H Rutten-van Mölken, Floortje E van Nooten, Marion Lindemann, et al.
Respiratory Research|November 19, 2008
One-year treatment with mometasone furoate in chronic obstructive pulmonary diseasePeter M A Calverley, Stephen Rennard, Harold S Nelson, et al.
Lancet (London, England)|September 1, 2009
Budesonide and the risk of pneumonia: a meta-analysis of individual patient dataDon D Sin, Donald Tashkin, Xuekui Zhang, et al.
Respiratory Medicine|January 22, 2013
Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trialFernando J Martinez, Joseph Boscia, Gregory Feldman, et al.
Chest|November 3, 2012
Efficacy of roflumilast in the COPD frequent exacerbator phenotypeJadwiga A Wedzicha, Klaus F Rabe, Fernando J Martinez, et al.
The European Respiratory Journal|November 1, 2014
Variability of within-breath reactance in COPD patients and its association with dyspnoeaBernt B Aarli, Peter M A Calverley, Robert L Jensen, et al.
Thorax|August 13, 2013
Commentary: the British Thoracic Society guideline on pulmonary rehabilitation in adultsCharlotte E Bolton, Sally J Singh, Paul P Walker, et al.
Respiratory Research|August 1, 2013
Factors associated with change in exacerbation frequency in COPDGavin C Donaldson, Hanna Müllerova, Nicholas Locantore, et al.
Pageof 15